SCHEMBL8736261

SCHEMBL8736261

O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2cc(O)ccc21

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 7/20 0.81
CYP3A4 P08684 3/20 0.81
ALOX15 P16050 2/20 0.81
TSHR P16473 2/20 0.81
ADRA1D P25100 2/20 0.81
ADRA1A P35348 2/20 0.81
ADRA1B P35368 2/20 0.81
KCNH2 Q12809 2/20 0.81
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
PBRM1 Q86U86 1/20 0.45
PDK2 Q15119 2/20 0.37
LOXL2 Q9Y4K0 1/20 0.36
ESR1 P03372 1/20 0.33
MAOA P21397 1/20 0.33
UGT1A1 P22309 1/20 0.33
MAOB P27338 1/20 0.33
ESR2 Q92731 1/20 0.33
CYP19A1 P11511 1/20 0.32
CHRM5 P08912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8377475 0.93 KCNQ2 (0.67) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL1111017 0.90 KCNQ2 (1.00) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL29381857 0.90 KCNQ2 (1.00) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL7358470 0.85 KCNQ2 (0.90) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL8381380 0.83 KCNQ2 (0.76) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL13002456 0.80 KCNQ2 (0.79) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL8058909 0.79 KCNQ2 (0.78) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL8377502 0.77 KCNQ2 (0.74) KCNQ2CYP3A4ALOX15TSHRADRA1D
SCHEMBL12998025 0.76 KCNQ2 (0.68) KCNQ2CYP3A4ALOX15TSHRADRA1D
Hydrochloric Acid SCHEMBL28745488 0.76 KCNQ2 (0.72) KCNQ2CYP3A4ALOX15TSHRADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750528-A Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-05-12 US claimed
WO-1994024131-A1 NOVEL POLYCYCLIC SYSTEMS, AND DERIVATIVES THEREOF, AS NEUROTRANSMITTER RELEASE ENHANCER USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-27 WO claimed
US-5750528-A Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-05-12 US disclosed
US-5594001-A Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-01-14 US disclosed
WO-1994024131-A1 NOVEL POLYCYCLIC SYSTEMS, AND DERIVATIVES THEREOF, AS NEUROTRANSMITTER RELEASE ENHANCER USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-27 WO disclosed